328 related articles for article (PubMed ID: 19176510)
21. Immunohistochemical expression of estrogen receptor beta in normal and tumoral canine mammary glands.
Martín de las Mulas J; Ordás J; Millán MY; Chacón F; De Lara M; Espinosa de los Monteros A; Reymundo C; Jover A
Vet Pathol; 2004 May; 41(3):269-72. PubMed ID: 15133176
[TBL] [Abstract][Full Text] [Related]
22. Complex p63 mRNA isoform expression patterns in squamous cell carcinoma of the head and neck.
Thurfjell N; Coates PJ; Uusitalo T; Mahani D; Dabelsteen E; Dahlqvist A; Sjöström B; Roos G; Nylander K
Int J Oncol; 2004 Jul; 25(1):27-35. PubMed ID: 15201986
[TBL] [Abstract][Full Text] [Related]
23. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.
Boldrup L; Coates PJ; Gu X; Nylander K
J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121
[TBL] [Abstract][Full Text] [Related]
24. Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors.
Lee CH; Kweon OK
J Vet Sci; 2002 Dec; 3(4):321-5. PubMed ID: 12819382
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical detection of p63 in testicular germ cell neoplasia.
Emanuel PO; Unger PD; Burstein DE
Ann Diagn Pathol; 2006 Oct; 10(5):269-73. PubMed ID: 16979518
[TBL] [Abstract][Full Text] [Related]
26. Expression of maspin in mammary gland tumors of the dog.
Espinosa de los Monteros A; Millán MY; Ramírez GA; Ordás J; Reymundo C; Martín de las Mulas J
Vet Pathol; 2005 May; 42(3):250-7. PubMed ID: 15872371
[TBL] [Abstract][Full Text] [Related]
27. The role of CD44 adhesion factor in canine mammary carcinomas.
Madrazo J; García-Fernández RA; García-Iglesias MJ; Durán AJ; Espinosa J; Pérez-Martínez C
Vet J; 2009 Jun; 180(3):371-6. PubMed ID: 18299241
[TBL] [Abstract][Full Text] [Related]
28. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
[TBL] [Abstract][Full Text] [Related]
29. Tumor-associated carbohydrate antigens: Sialyl Lea and T/Tn antigens in canine mammary tumors.
Nowak M; Madej J; Dziegiel P; Lopuszynski W; Rodo A; Ugorski M
Vet Pathol; 2009 Mar; 46(2):222-6. PubMed ID: 19261632
[TBL] [Abstract][Full Text] [Related]
30. Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73.
Petitjean A; Ruptier C; Tribollet V; Hautefeuille A; Chardon F; Cavard C; Puisieux A; Hainaut P; Caron de Fromentel C
Carcinogenesis; 2008 Feb; 29(2):273-81. PubMed ID: 18048390
[TBL] [Abstract][Full Text] [Related]
31. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of C5a receptor (CD88) mRNA in canine mammary tumors.
Hezmee MN; Kyaw-Tanner M; Lee JY; Shiels IA; Rolfe B; Woodruff T; Mills PC
Vet Immunol Immunopathol; 2011 Jan; 139(1):50-6. PubMed ID: 20846729
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
Amorim I; Lopes CC; Faustino AM; Pereira PD
J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
[TBL] [Abstract][Full Text] [Related]
34. Expression of CD44 in canine mammary tumours.
Paltian V; Alldinger S; Baumgärtner W; Wohlsein P
J Comp Pathol; 2009 Nov; 141(4):237-47. PubMed ID: 19592009
[TBL] [Abstract][Full Text] [Related]
35. Occurrence and expression of p53 suppressor gene and c-Myc oncogene in dog eyelid tumors.
Lopes RA; Cardoso TC; Luvizotto MC; de Andrade AL
Vet Ophthalmol; 2010 Mar; 13(2):69-75. PubMed ID: 20447023
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical expression of TopBP1 in feline mammary neoplasia in relation to histological grade, Ki67, ERalpha and p53.
Morris JS; Nixon C; Bruck A; Nasir L; Morgan IM; Philbey AW
Vet J; 2008 Feb; 175(2):218-26. PubMed ID: 17336111
[TBL] [Abstract][Full Text] [Related]
37. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases.
Plaza JA; Ortega PF; Stockman DL; Suster S
J Cutan Pathol; 2010 Apr; 37(4):403-10. PubMed ID: 20377670
[TBL] [Abstract][Full Text] [Related]
38. Expression of the GLUT1 glucose transporter, p63 and p53 in thyroid carcinomas.
Kim YW; Do IG; Park YK
Pathol Res Pract; 2006; 202(11):759-65. PubMed ID: 17029809
[TBL] [Abstract][Full Text] [Related]
39. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
40. Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.
Faustino AM; van Garderen E; Schalken JA; Nederbragt H
J Comp Pathol; 2002 Jan; 126(1):1-8. PubMed ID: 11814316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
